| Ausstehende Aktien | 49,428,177 shares |
| Insider-Aktien | 29.478.997 shares |
| Insider-Besitz | 59,64 % |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Nettoanzahl der Insider, die kaufen (Rang)
N/A
Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).
Prozent des Streubesitzes von Insidern gekauft (Rang)
N/A
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Aadi Bioscience, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in AADI / Aadi Bioscience, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in AADI / Aadi Bioscience, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | 2026-05-14 | 4 | Dugan Margaret | WHWK | Common Stock | D | 3,9200 | 19.132 | 75 | 19.132 | ||||
| 2026-05-18 | 2026-05-14 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,9200 | 51.020 | 200 | 448.126 | ||||
| 2026-05-18 | 2026-05-14 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 3,9200 | 38.265 | 150 | 333.489 | ||||
| 2026-05-18 | 2026-05-14 | 4 | Lennon David James | WHWK | Common Stock | D | 3,9200 | 51.021 | 200 | 569.643 | ||||
| 2026-05-18 | 2026-05-14 | 4 | Castelein Caley | WHWK | Common Stock | D | 3,9200 | 255.102 | 1.000 | 274.796 | ||||
| 2026-04-17 | 2026-04-16 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 4,1300 | -141.600 | -585 | 295.224 | ||||
| 2026-04-17 | 2026-04-15 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 3,8600 | -77.000 | -297 | 436.824 | ||||
| 2026-04-15 | 2026-04-14 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,6400 | -92.460 | -337 | 397.106 | ||||
| 2026-04-15 | 2026-04-13 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,4600 | -26.389 | -91 | 489.566 | ||||
| 2026-04-13 | 2026-04-10 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,4300 | -6.596 | -23 | 515.955 | ||||
| 2026-04-13 | 2026-04-09 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,5700 | -50.000 | -178 | 522.551 | ||||
| 2026-04-10 | 2026-04-09 | 4 | Lennon David James | WHWK | Common Stock | D | 3,3800 | -14.500 | -49 | 518.622 | ||||
| 2026-04-08 | 2026-04-08 | 4 | Lennon David James | WHWK | Common Stock | D | 3,4000 | -63.945 | -217 | 533.122 | ||||
| 2026-04-08 | 2026-04-07 | 4 | Lennon David James | WHWK | Common Stock | D | 3,4300 | -94.087 | -323 | 597.067 | ||||
| 2026-04-08 | 2026-04-06 | 4 | Lennon David James | WHWK | Common Stock | D | 3,5100 | -102.395 | -359 | 691.154 | ||||
| 2026-04-03 | 2026-04-01 | 4 | BALL BRYAN | WHWK | Common Stock | D | 366.532 | 572.551 | ||||||
| 2026-04-03 | 2026-04-01 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 473.902 | 502.002 | ||||||
| 2026-04-03 | 2026-04-02 | 4 | Lennon David James | WHWK | Common Stock | D | 3,4800 | -26.858 | -93 | 793.549 | ||||
| 2026-04-03 | 2026-04-01 | 4 | Lennon David James | WHWK | Common Stock | D | 775.828 | 820.407 | ||||||
| 2026-03-10 | 2026-03-02 | 4 | BALL BRYAN | WHWK | Common Stock | D | 3,3096 | -1.834 | -6 | 206.019 | ||||
| 2026-03-10 | 2026-03-01 | 4 | BALL BRYAN | WHWK | Common Stock | D | 5.000 | 207.853 | ||||||
| 2026-03-10 | 2026-03-02 | 4 | Lennon David James | WHWK | Common Stock | D | 3,3096 | -5.100 | -17 | 44.579 | ||||
| 2026-03-10 | 2026-03-01 | 4 | Lennon David James | WHWK | Common Stock | D | 16.250 | 49.679 | ||||||
| 2026-03-10 | 2026-03-02 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 3,3096 | -2.594 | -9 | 28.100 | ||||
| 2026-03-10 | 2026-03-01 | 4 | Giacobello Scott M. | WHWK | Common Stock | D | 6.750 | 30.694 | ||||||
| 2025-03-05 | 2025-03-04 | 4 | Dalal Anupam | AADI | Common Stock | I | 2,4000 | 1.561.000 | 3.746 | 3.410.402 | ||||
| 2025-03-04 | 2025-03-04 | 4 | Castelein Caley | AADI | Common Stock | I | 2,4000 | 1.666.000 | 3.998 | 2.165.998 | ||||
| 2025-03-04 | 2025-03-04 | 4 | Zhao Baiteng | AADI | Common Stock | I | 2,4000 | 1.250.000 | 3.000 | 1.250.000 | ||||
| 2025-03-04 | 2025-03-04 | 4 | BALL BRYAN | AADI | Common Stock | D | 2,4000 | 100.000 | 240 | 202.853 | ||||
| 2025-03-04 | 2025-03-03 | 4 | BALL BRYAN | AADI | Common Stock | D | 2,3500 | -2.147 | -5 | 102.853 | ||||
| 2025-03-04 | 2025-03-01 | 4 | BALL BRYAN | AADI | Common Stock | D | 5.000 | 105.000 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Giacobello Scott M. | AADI | Common Stock | D | 2,3500 | -2.806 | -7 | 23.944 | ||||
| 2025-03-03 | 2025-03-01 | 4 | Giacobello Scott M. | AADI | Common Stock | D | 6.750 | 26.750 | ||||||
| 2025-03-03 | 2025-03-03 | 4 | Lennon David James | AADI | Common Stock | D | 2,3500 | -5.690 | -13 | 33.429 | ||||
| 2025-03-03 | 2025-03-01 | 4 | Lennon David James | AADI | Common Stock | D | 16.250 | 39.119 | ||||||
| 2024-10-03 | 2024-10-03 | 4 | Lennon David James | AADI | Common Stock | D | 1,9400 | -9.689 | -19 | 22.869 | ||||
| 2024-10-03 | 2024-10-02 | 4 | Lennon David James | AADI | Common Stock | D | 32.558 | 32.558 | ||||||
| 2024-09-05 | 2024-09-03 | 4 | Desai Neil | AADI | Common Stock | I | 1,7079 | -40.000 | -68 | 1.171.543 | ||||
| 2024-08-05 | 2024-08-05 | 4 | Desai Neil | AADI | Common Stock | I | 1,3437 | -5.652 | -8 | 1.211.543 | ||||
| 2024-08-05 | 2024-08-02 | 4 | Desai Neil | AADI | Common Stock | I | 1,4105 | -18.933 | -27 | 1.217.195 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,4956 | -15.415 | -23 | 1.236.128 | ||||
| 2024-07-02 | 2024-07-02 | 4 | Desai Neil | AADI | Common Stock | I | 1,3421 | -8.652 | -12 | 1.251.543 | ||||
| 2024-07-02 | 2024-07-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,4548 | -31.348 | -46 | 1.260.195 | ||||
| 2024-06-05 | 2024-06-04 | 4 | Desai Neil | AADI | Common Stock | I | 1,7674 | -20.225 | -36 | 1.291.543 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Desai Neil | AADI | Common Stock | I | 1,8086 | -19.775 | -36 | 1.311.768 | ||||
| 2024-05-01 | 2024-05-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,9296 | -40.000 | -77 | 1.331.543 | ||||
| 2024-04-26 | 3 | BALL BRYAN | AADI | Common Stock | D | 100.000 | ||||||||
| 2024-04-03 | 2024-04-02 | 4 | Desai Neil | AADI | Common Stock | I | 2,2275 | -22.228 | -50 | 1.371.543 | ||||
| 2024-04-03 | 2024-04-01 | 4 | Desai Neil | AADI | Common Stock | I | 2,3127 | -17.772 | -41 | 1.393.771 | ||||
| 2024-03-04 | 2024-03-04 | 4 | Desai Neil | AADI | Common Stock | I | 2,0994 | -14.964 | -31 | 1.411.543 | ||||
| 2024-03-04 | 2024-03-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,9687 | -27.036 | -53 | 1.426.507 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Desai Neil | AADI | Common Stock | I | 1,7445 | -42.000 | -73 | 1.453.543 | ||||
| 2024-01-02 | 2024-01-02 | 4 | Desai Neil | AADI | Common Stock | I | 2,0607 | -42.000 | -87 | 1.495.543 | ||||
| 2023-12-07 | 2023-12-06 | 4 | Desai Neil | AADI | Common Stock | I | 4,8194 | -7.037 | -34 | 1.537.543 | ||||
| 2023-12-05 | 2023-12-05 | 4 | Desai Neil | AADI | Common Stock | I | 5,0153 | -15.740 | -79 | 1.544.580 | ||||
| 2023-12-05 | 2023-12-04 | 4 | Desai Neil | AADI | Common Stock | I | 5,1477 | -10.876 | -56 | 1.560.320 | ||||
| 2023-12-05 | 2023-12-01 | 4 | Desai Neil | AADI | Common Stock | I | 5,1373 | -8.347 | -43 | 1.571.196 | ||||
| 2023-11-02 | 2023-11-02 | 4 | Desai Neil | AADI | Common Stock | I | 4,4566 | -31.662 | -141 | 1.579.543 | ||||
| 2023-11-02 | 2023-11-01 | 4 | Desai Neil | AADI | Common Stock | I | 4,3185 | -10.338 | -45 | 1.611.205 | ||||
| 2023-10-03 | 2023-10-03 | 4 | Desai Neil | AADI | Common Stock | I | 4,0961 | -16.431 | -67 | 1.621.543 | ||||
| 2023-10-03 | 2023-10-02 | 4 | Desai Neil | AADI | Common Stock | I | 4,3685 | -25.569 | -112 | 1.637.974 | ||||
| 2023-09-06 | 2023-09-06 | 4 | Desai Neil | AADI | Common Stock | I | 5,2928 | -7.111 | -38 | 1.663.543 | ||||
| 2023-09-06 | 2023-09-05 | 4 | Desai Neil | AADI | Common Stock | I | 5,6341 | -21.000 | -118 | 1.670.654 | ||||
| 2023-09-06 | 2023-09-01 | 4 | Desai Neil | AADI | Common Stock | I | 5,9668 | -13.889 | -83 | 1.691.654 | ||||
| 2023-08-03 | 2023-08-02 | 4 | Desai Neil | AADI | Common Stock | I | 5,1970 | -19.290 | -100 | 1.705.543 | ||||
| 2023-08-03 | 2023-08-01 | 4 | Desai Neil | AADI | Common Stock | I | 5,2190 | -22.710 | -119 | 1.724.833 | ||||
| 2023-07-06 | 2023-07-06 | 4 | Desai Neil | AADI | Common Stock | I | 6,2716 | -15.829 | -99 | 1.747.543 | ||||
| 2023-07-06 | 2023-07-05 | 4 | Desai Neil | AADI | Common Stock | I | 6,5471 | -16.171 | -106 | 1.763.372 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Desai Neil | AADI | Common Stock | I | 6,6446 | -10.000 | -66 | 1.779.543 | ||||
| 2023-06-06 | 2023-06-06 | 4 | Desai Neil | AADI | Common Stock | I | 8,1891 | -7.260 | -59 | 1.789.543 | ||||
| 2023-06-05 | 2023-06-05 | 4 | Desai Neil | AADI | Common Stock | I | 8,1096 | -17.315 | -140 | 1.796.803 | ||||
| 2023-06-05 | 2023-06-02 | 4 | Desai Neil | AADI | Common Stock | I | 7,9901 | -12.443 | -99 | 1.814.118 | ||||
| 2023-06-05 | 2023-06-01 | 4 | Desai Neil | AADI | Common Stock | I | 7,9222 | -4.982 | -39 | 1.826.561 | ||||
| 2023-05-05 | 2023-05-04 | 4 | Desai Neil | AADI | Common Stock | I | 7,5682 | -2.305 | -17 | 1.831.543 | ||||
| 2023-05-03 | 2023-05-03 | 4 | Desai Neil | AADI | Common Stock | I | 7,6768 | -7.695 | -59 | 1.833.848 | ||||
| 2023-05-03 | 2023-05-02 | 4 | Desai Neil | AADI | Common Stock | I | 7,4757 | -7.521 | -56 | 1.841.543 | ||||
| 2023-05-03 | 2023-05-01 | 4 | Desai Neil | AADI | Common Stock | I | 7,7983 | -24.479 | -191 | 1.849.064 | ||||
| 2023-04-06 | 2023-04-06 | 4 | Desai Neil | AADI | Common Stock | I | 7,0927 | -12.212 | -87 | 1.873.543 | ||||
| 2023-04-05 | 2023-04-05 | 4 | Desai Neil | AADI | Common Stock | I | 7,2350 | -7.336 | -53 | 1.885.755 | ||||
| 2023-04-05 | 2023-04-04 | 4 | Desai Neil | AADI | Common Stock | I | 7,3029 | -12.869 | -94 | 1.893.091 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Desai Neil | AADI | Common Stock | I | 7,4460 | -9.583 | -71 | 1.905.960 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Castelein Caley | AADI | Common Stock | I | 12,5000 | 240.000 | 3.000 | 499.998 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Dalal Anupam | AADI | Common Stock | I | 12,5000 | 320.000 | 4.000 | 1.849.402 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Delaney Brendan | AADI | Common Stock | D | 12,5000 | 20.000 | 250 | 20.000 | ||||
| 2022-09-27 | 2022-09-26 | 4 | Giacobello Scott M. | AADI | Common Stock | D | 12,5000 | 20.000 | 250 | 20.000 | ||||
| 2022-09-26 | 2022-09-22 | 4 | Aghazadeh Behzad See footnotes | AADI | Common Stock, $0.0001 par value per share ("Common Stock") | I | 12,5000 | 1.260.000 | 15.750 | 3.471.752 | ||||
| 2022-04-05 | 2022-04-01 | 4 | ITRI LORETTTA M | AADI | Stock option (right to buy) | D | 17,24 | 67.300 | 67.300 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Delaney Brendan | AADI | Stock option (right to buy) | D | 17,24 | 61.000 | 61.000 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Giacobello Scott M. | AADI | Stock option (right to buy) | D | 17,24 | 46.400 | 46.400 | |||||
| 2022-04-05 | 2022-04-01 | 4 | Desai Neil | AADI | Stock option (right to buy) | D | 17,24 | 153.300 | 153.300 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Desai Neil | AADI | Common Stock | I | 20,0658 | -3.550 | -71 | 1.915.543 | ||||
| 2021-10-25 | 2021-10-21 | 4 | ITRI LORETTTA M | AADI | Stock option (right to buy) | D | 26,85 | 185.000 | 185.000 | |||||
| 2021-10-25 | 3 | ITRI LORETTTA M By spouse | AADI | Common Stock | I | 3.000 | ||||||||
| 2021-09-22 | 2021-09-20 | 4 | Delaney Brendan | AADI | Stock option (right to buy) | D | 29,09 | 260.000 | 260.000 | |||||
| 2021-09-10 | 2021-09-08 | 4 | Desai Neil | AADI | Stock option (right to buy) | D | 27,67 | 125.000 | 125.000 | |||||
| 2021-09-10 | 2021-09-08 | 4 | Reeve Emma | AADI | Stock option (right to buy) | D | 27,67 | 16.486 | 16.486 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Hehenberger Karin M. | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Maroun Richard E | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-31 | 3 | Desai Neil | AADI | Common Stock | I | 1.919.093 | ||||||||
| 2021-08-31 | 3 | Desai Neil | AADI | Common Stock | I | 639.698 | ||||||||
| 2021-08-31 | 2021-08-26 | 4/A | Dalal Anupam | AADI | Common Stock | I | 13,0770 | 1.529.402 | 20.000 | 1.529.402 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Castelein Caley | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-30 | 2021-08-26 | 4 | Castelein Caley | AADI | Common Stock | I | 13,0770 | 259.998 | 3.400 | 259.998 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Dalal Anupam | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-30 | 2021-08-26 | 4 | Dalal Anupam | AADI | Common Stock | I | 13,0770 | 1.529.402 | 20.000 | 1.529.402 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Aghazadeh Behzad | AADI | Stock option (right to buy) | D | 26,00 | 17.549 | 17.549 | |||||
| 2021-08-30 | 2021-08-26 | 4 | Aghazadeh Behzad See footnotes | AADI | Common Stock, $0.0001 par value per share ("Common Stock") | I | 13,0770 | 1.911.752 | 25.000 | 2.211.752 | ||||
| 2021-08-30 | 3 | Avoro Ventures LLC See footnotes | AADI | Common Stock, par value $0.0001 per share | I | 300.000 | ||||||||
| 2021-07-02 | 2021-06-30 | 4 | Castelein Caley | ARPO | Common Stock | D | 1,5200 | 7.811 | 12 | 295.414 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Prelack Steven | ARPO | Common Stock | D | 1,5200 | 12.334 | 19 | 24.485 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Cohen Cheryl | ARPO | Common Stock | D | 1,5200 | 8.140 | 12 | 16.160 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Dalal Anupam | ARPO | Common Stock | D | 1,5200 | 7.400 | 11 | 16.959 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Dugel Pravin | ARPO | Common Stock | D | 1,5200 | 6.331 | 10 | 12.568 | ||||
| 2021-06-22 | 2021-06-17 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 1,87 | 100.000 | 100.000 | |||||
| 2021-04-02 | 2021-03-31 | 4 | Dalal Anupam | ARPO | Common Stock | D | 1,5430 | 7.290 | 11 | 9.559 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Prelack Steven | ARPO | Common Stock | D | 1,5430 | 12.151 | 19 | 12.151 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Castelein Caley | ARPO | Common Stock | D | 1,5430 | 7.696 | 12 | 287.603 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Dugel Pravin | ARPO | Common Stock | D | 1,5430 | 6.237 | 10 | 6.237 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Cohen Cheryl | ARPO | Common Stock | D | 1,5430 | 8.020 | 12 | 8.020 | ||||
| 2021-02-03 | 2021-02-01 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2021-02-03 | 2021-02-01 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2021-02-03 | 2021-02-01 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2021-02-03 | 2021-02-01 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 1,46 | 17.857 | 17.857 | |||||
| 2020-12-10 | 2020-12-08 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Stock Option (Right to Buy) | I | 0,96 | -21.400 | 0 | |||||
| 2020-12-10 | 2020-12-08 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Common Stock | I | 1,9600 | -21.400 | -42 | 0 | ||||
| 2020-12-10 | 2020-12-08 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Common Stock | I | 0,9600 | 21.400 | 21 | 21.400 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Prelack Steven | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 1,22 | 52.144 | 52.144 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Marek Regina | ARPO | Stock Option (Right to Buy) | D | 0,52 | 93.000 | 93.000 | |||||
| 2020-03-18 | 2020-03-16 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 0,52 | 129.000 | 129.000 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 0,52 | 155.000 | 155.000 | |||||
| 2019-11-06 | 2019-11-04 | 4 | Marek Regina | ARPO | Stock Option (Right to Buy) | D | 0,56 | 44.300 | 44.300 | |||||
| 2019-10-24 | 3 | Marek Regina | ARPO | Common Stock | D | 23.250 | ||||||||
| 2019-10-24 | 3 | Marek Regina | ARPO | Common Stock | D | 23.250 | ||||||||
| 2019-10-24 | 3 | Marek Regina | ARPO | Common Stock | D | 23.250 | ||||||||
| 2019-07-10 | 2019-07-10 | 4 | Gardner Joseph H. | ARPO | Common Stock | D | 0,8147 | 5.000 | 4 | 453.019 | ||||
| 2019-07-08 | 2019-07-03 | 4 | Gardner Joseph H. | ARPO | Common Stock | D | 0,8970 | 5.000 | 4 | 448.019 | ||||
| 2019-06-19 | 2019-06-18 | 4 | Prelack Steven | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Satter Muneer A | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Khuong Chau Quang | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-06-19 | 2019-06-18 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 0,96 | 21.400 | 21.400 | |||||
| 2019-05-16 | 2019-05-14 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 1,04 | 266.550 | 266.550 | |||||
| 2019-05-16 | 2019-05-14 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 1,04 | 63.250 | 63.250 | |||||
| 2019-05-16 | 2019-05-14 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 1,04 | 430.500 | 430.500 | |||||
| 2019-05-16 | 2019-05-14 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 1,04 | 169.500 | 169.500 | |||||
| 2019-05-16 | 2019-05-14 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 1,04 | 349.350 | 349.350 | |||||
| 2019-05-16 | 2019-05-14 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 1,04 | 709.050 | 709.050 | |||||
| 2019-04-29 | 2019-04-26 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -138.704 | -143 | 4.049.804 | ||||
| 2019-04-29 | 2019-04-25 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -563.096 | -580 | 4.188.508 | ||||
| 2019-04-24 | 2019-04-24 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -16.403 | -17 | 4.751.604 | ||||
| 2019-04-24 | 2019-04-23 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0300 | -27.554 | -28 | 4.768.007 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9700 | -7.100 | -7 | 4.795.561 | ||||
| 2019-04-15 | 2019-04-15 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9900 | -28.794 | -29 | 4.802.661 | ||||
| 2019-04-15 | 2019-04-12 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0400 | -30.908 | -32 | 4.831.455 | ||||
| 2019-04-15 | 2019-04-11 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0800 | -57.438 | -62 | 4.862.363 | ||||
| 2019-04-10 | 2019-04-10 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0900 | -140.230 | -153 | 4.919.801 | ||||
| 2019-04-10 | 2019-04-09 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0100 | -32.991 | -33 | 5.060.031 | ||||
| 2019-04-10 | 2019-04-08 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0200 | -27.525 | -28 | 5.093.022 | ||||
| 2019-04-05 | 2019-04-05 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0200 | -24.661 | -25 | 5.120.547 | ||||
| 2019-04-05 | 2019-04-04 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0100 | -47.900 | -48 | 5.145.208 | ||||
| 2019-04-05 | 2019-04-03 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9600 | -58.033 | -56 | 5.193.108 | ||||
| 2019-04-02 | 2019-04-02 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9700 | -51.754 | -50 | 5.251.141 | ||||
| 2019-04-02 | 2019-04-01 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9500 | -116.909 | -111 | 5.302.895 | ||||
| 2019-04-02 | 2019-03-29 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9100 | -63.100 | -57 | 5.419.804 | ||||
| 2019-03-28 | 2019-03-28 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9400 | -88.835 | -84 | 5.482.904 | ||||
| 2019-03-28 | 2019-03-27 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 0,9900 | -50.749 | -50 | 5.571.739 | ||||
| 2019-03-28 | 2019-03-26 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 1,0100 | -177.762 | -180 | 5.622.488 | ||||
| 2019-02-20 | 2019-02-15 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 3,27 | 215.328 | 215.328 | |||||
| 2019-02-20 | 2019-02-15 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 3,27 | 125.000 | 125.000 | |||||
| 2019-02-20 | 2019-02-15 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 3,27 | 365.000 | 365.000 | |||||
| 2019-02-20 | 2019-02-15 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 3,27 | 150.000 | 150.000 | |||||
| 2019-02-20 | 2019-02-15 | 4 | PAKOLA STEVE | ARPO | Stock Option (Right to Buy) | D | 3,27 | 125.000 | 125.000 | |||||
| 2019-02-13 | 2018-12-12 | 5 | Gardner Joseph H. | ARPO | Common Stock | I | 150.000 | 150.000 | ||||||
| 2019-02-13 | 2018-12-12 | 5 | Gardner Joseph H. | ARPO | Common Stock | D | -150.000 | 443.019 | ||||||
| 2019-01-10 | 2019-01-10 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,4537 | 23.818 | 58 | 5.621.835 | ||||
| 2019-01-10 | 2019-01-09 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,3938 | 20.000 | 48 | 5.598.017 | ||||
| 2019-01-10 | 2019-01-08 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1986 | 20.000 | 44 | 5.578.017 | ||||
| 2019-01-07 | 2019-01-07 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1779 | 20.000 | 44 | 5.558.017 | ||||
| 2019-01-07 | 2019-01-04 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1198 | 20.000 | 42 | 5.538.017 | ||||
| 2019-01-07 | 2019-01-03 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0754 | 20.000 | 42 | 5.518.017 | ||||
| 2019-01-02 | 2019-01-02 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9419 | 20.000 | 39 | 5.498.017 | ||||
| 2019-01-02 | 2018-12-31 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,7450 | 20.000 | 35 | 5.478.017 | ||||
| 2019-01-02 | 2018-12-28 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,7186 | 20.000 | 34 | 5.458.017 | ||||
| 2018-12-27 | 2018-12-27 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,6705 | 20.000 | 33 | 5.438.017 | ||||
| 2018-12-27 | 2018-12-26 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,6927 | 20.000 | 34 | 5.418.017 | ||||
| 2018-12-27 | 2018-12-21 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,8435 | 20.000 | 37 | 5.398.017 | ||||
| 2018-12-20 | 2018-12-20 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,8492 | 20.000 | 37 | 5.378.017 | ||||
| 2018-12-20 | 2018-12-19 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9192 | 20.000 | 38 | 5.358.017 | ||||
| 2018-12-20 | 2018-12-18 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9928 | 20.000 | 40 | 5.338.017 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0047 | 20.000 | 40 | 5.318.017 | ||||
| 2018-12-14 | 2018-12-13 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0154 | 20.000 | 40 | 5.298.017 | ||||
| 2018-12-14 | 2018-12-12 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0469 | 20.000 | 41 | 5.278.017 | ||||
| 2018-12-11 | 2018-12-11 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0923 | 20.000 | 42 | 5.258.017 | ||||
| 2018-12-11 | 2018-12-10 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1304 | 20.000 | 43 | 5.238.017 | ||||
| 2018-12-11 | 2018-12-07 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1394 | 20.000 | 43 | 5.218.017 | ||||
| 2018-12-06 | 2018-12-06 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,1792 | 20.000 | 44 | 5.198.017 | ||||
| 2018-12-06 | 2018-12-04 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0997 | 20.000 | 42 | 5.178.017 | ||||
| 2018-12-06 | 2018-12-03 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9887 | 20.000 | 40 | 5.158.017 | ||||
| 2018-11-30 | 2018-11-30 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9846 | 20.000 | 40 | 5.138.017 | ||||
| 2018-11-30 | 2018-11-29 | 4 | Satter Muneer A | ARPO | Common Stock | I | 2,0059 | 20.000 | 40 | 5.118.017 | ||||
| 2018-11-30 | 2018-11-28 | 4 | Satter Muneer A | ARPO | Common Stock | I | 1,9357 | 20.000 | 39 | 5.098.017 | ||||
| 2018-11-16 | 2018-10-26 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 2,05 | 2.500 | 2.500 | |||||
| 2018-11-14 | 2018-11-12 | 4 | HOFFMAN STEPHEN J | ARPO | Common Stock | D | 2,0100 | 30.000 | 60 | 31.967 | ||||
| 2018-11-14 | 2018-11-09 | 4 | HOFFMAN STEPHEN J | ARPO | Common Stock | D | 1,9500 | 1.967 | 4 | 1.967 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Castelein Caley | ARPO | Common Stock | I | -1.603.526 | 0 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Castelein Caley | ARPO | Common Stock | D | 268.987 | 279.907 | ||||||
| 2018-08-22 | 2018-08-20 | 4 | Novartis Bioventures Ltd | ARPO | Common Stock | I | 3,9000 | -5.300 | -21 | 5.800.250 | ||||
| 2018-07-02 | 2018-06-28 | 4 | ORBIMED ADVISORS LLC See Footnotes | ARPO | Common Stock | I | 3,8500 | 777.500 | 2.993 | 5.193.946 | ||||
| 2018-07-02 | 2018-06-28 | 4 | Khuong Chau Quang See Footnotes | ARPO | Common Stock | I | 3,8500 | 777.500 | 2.993 | 5.193.946 | ||||
| 2018-06-29 | 2018-06-28 | 4 | Satter Muneer A | ARPO | Common Stock | I | 3,8500 | 1.818.182 | 7.000 | 5.078.017 | ||||
| 2018-06-22 | 2018-06-20 | 4 | Dalal Anupam | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Satter Muneer A | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Castelein Caley | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Prelack Steven | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Dugel Pravin | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Khuong Chau Quang | ARPO | Stock Option (Right to Buy) | D | 4,00 | 21.400 | 21.400 | |||||
| 2018-06-22 | 2018-06-20 | 4 | Cohen Cheryl | ARPO | Stock Option (Right to Buy) | D | 4,00 | 42.800 | 42.800 | |||||
| 2018-05-21 | 3 | DESAI DHAVAL | ARPO | Common Stock | D | 150.684 | ||||||||
| 2018-05-21 | 3 | DESAI DHAVAL | ARPO | Common Stock | D | 150.684 | ||||||||
| 2018-05-21 | 3 | DESAI DHAVAL | ARPO | Common Stock | D | 150.684 | ||||||||
| 2018-04-25 | 2018-04-23 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 3,59 | 150.000 | 150.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | PAKOLA STEVE | ARPO | Stock Option (Right to Buy) | D | 3,59 | 100.000 | 100.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 3,59 | 144.000 | 144.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | PETERS KEVIN G. | ARPO | Stock Option (Right to Buy) | D | 3,59 | 100.000 | 100.000 | |||||
| 2018-04-25 | 2018-04-23 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 3,59 | 300.000 | 300.000 | |||||
| 2018-03-23 | 2018-03-23 | 4 | Satter Muneer A | ARPO | Common Stock | I | 5,0000 | 1.000 | 5 | 3.259.835 | ||||
| 2018-03-23 | 2018-03-21 | 4 | Satter Muneer A | ARPO | Common Stock | I | 4,8475 | 4.000 | 19 | 3.258.835 | ||||
| 2018-03-21 | 2018-03-20 | 4 | Satter Muneer A | ARPO | Common Stock | I | 4,9741 | 5.400 | 27 | 3.254.835 | ||||
| 2018-03-21 | 2018-03-19 | 4 | Satter Muneer A | ARPO | Common Stock | I | 4,9638 | 7.600 | 38 | 3.249.435 | ||||
| 2018-02-14 | 2017-12-22 | 5 | Dalal Anupam | ARPO | Common Stock | D | 2.269 | 2.269 | ||||||
| 2018-02-14 | 2017-12-22 | 5 | Dalal Anupam | ARPO | Common Stock | I | -7.882 | 0 | ||||||
| 2018-02-14 | 2017-12-22 | 5 | Castelein Caley | ARPO | Common Stock | I | 10.920 | 10.920 | ||||||
| 2018-02-14 | 2017-12-22 | 5 | Castelein Caley | ARPO | Common Stock | I | -7.882 | 1.603.526 | ||||||
| 2017-12-18 | 2017-12-14 | 4 | ROGERS MICHAEL W | ARPO | Stock Option (Right to Buy) | D | 5,50 | 5,5000 | 293.006 | 1.612 | 0 | |||
| 2017-12-18 | 2017-12-14 | 4 | Gardner Joseph H. | ARPO | Stock Option (Right to Buy) | D | 5,50 | 5,5000 | 135.000 | 742 | 0 | |||
| 2017-12-18 | 2017-12-14 | 4 | HOFFMAN STEPHEN J | ARPO | Stock Option (Right to Buy) | D | 5,50 | 5,5000 | 586.012 | 3.223 | 0 | |||
| 2017-03-17 | 3 | Khuong Chau Quang See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | Khuong Chau Quang See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | PETERS KEVIN G. | NONE | Common Stock | D | 633.788 | ||||||||
| 2017-03-17 | 3 | PETERS KEVIN G. | NONE | Common Stock | D | 633.788 | ||||||||
| 2017-03-17 | 3 | Dalal Anupam | NONE | Common Stock | I | 15.764 | ||||||||
| 2017-03-17 | 3 | Dalal Anupam | NONE | Common Stock | I | 15.764 | ||||||||
| 2017-03-17 | 3 | Gardner Joseph H. | NONE | Common Stock | D | 986.046 | ||||||||
| 2017-03-17 | 3 | Gardner Joseph H. | NONE | Common Stock | D | 986.046 | ||||||||
| 2017-03-17 | 3 | Castelein Caley See Footnotes | NONE | Common Stock | I | 2.422.816 | ||||||||
| 2017-03-17 | 3 | Castelein Caley See Footnotes | NONE | Common Stock | I | 2.422.816 | ||||||||
| 2017-03-17 | 3 | WEISS PAUL M See Footnotes | NONE | Common Stock | I | 2.607.730 | ||||||||
| 2017-03-17 | 3 | WEISS PAUL M See Footnotes | NONE | Common Stock | I | 2.607.730 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | ISALY SAMUEL D See Footnotes | NONE | Common Stock | I | 7.306.902 | ||||||||
| 2017-03-17 | 3 | NOVARTIS AG | NONE | Common Stock | I | 10.491.100 | ||||||||
| 2017-03-17 | 3 | NOVARTIS AG | NONE | Common Stock | I | 10.491.100 | ||||||||
| 2017-03-17 | 3 | NOVARTIS AG | NONE | Common Stock | I | 10.491.100 | ||||||||
| 2017-03-17 | 3 | Satter Muneer A | NONE | Common Stock | I | 4.243.670 | ||||||||
| 2017-03-17 | 3 | Satter Muneer A | NONE | Common Stock | I | 4.243.670 | ||||||||
| 2017-03-17 | 2017-03-15 | 4 | ORBIMED ADVISORS LLC See Footnotes | NONE | Common Stock | I | 5,0000 | 762.995 | 3.815 | 4.416.446 | ||||
| 2017-03-17 | 2017-03-15 | 4 | PETERS KEVIN G. | NONE | Common Stock | D | 5,0000 | 3.642 | 18 | 320.536 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Khuong Chau Quang See Footnotes | NONE | Common Stock | I | 5,0000 | 762.995 | 3.815 | 4.416.446 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Castelein Caley | NONE | Common Stock | I | 5,0000 | 400.000 | 2.000 | 1.611.408 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Novartis Bioventures Ltd | NONE | Common Stock | I | 5,0000 | 560.000 | 2.800 | 5.805.550 | ||||
| 2017-03-17 | 2017-03-15 | 4 | WEISS PAUL M See Footnotes | NONE | Common Stock | I | 5,0000 | 272.302 | 1.362 | 1.576.167 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Gardner Joseph H. | NONE | Common Stock | D | 5,0000 | 99.996 | 500 | 593.019 | ||||
| 2017-03-17 | 2017-03-15 | 4 | Satter Muneer A | NONE | Common Stock | I | 5,0000 | 1.120.000 | 5.600 | 3.241.835 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
